OnKure Therapeutics Inc. <OKUR.O>: Oppenheimer cuts target price to $14 from $30
OKUR•Related News
Trump says he would be OK with China building cars in US
XLY•
Fold director Bracebridge H. Young Jr acquires 20,000 Fold common shares worth $11,049 via family trust
FLD•
VinFast names founder's eldest son as its global chief executive
VFS•
Nasdaq trade halt continues <NFE.O> reason not available at 03:28 AM
NFE•
Nasdaq trade halt <NRSNW.O> halt news pending at 07:50 pm
NRSNW•